Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates
The Journal of Infectious Diseases · 11.08.2023 · 228 (3) · 281-286
DOI: 10.1093/infdis/jiad173 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 18.05.2023. Verfasst von Ciputra Adijaya Hartana und 15 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIAID NIH HHS, CCR NIH HHS.
Abstract (Originalsprache)
Immune mechanisms that modulate human immunodeficiency virus-1 (HIV-1) reservoir size in neonates are poorly understood. Using samples from neonates who initiated antiretroviral therapy shortly after birth, we demonstrate that interleukin-8–secreting CD4 T cells, which are selectively expanded in early infancy, are more resistant to HIV-1 infection and inversely correlated with the frequency of intact proviruses at birth. Moreover, newborns with HIV-1 infection displayed a distinct B-cell profile at birth, with reduction of memory B cells and expansion of plasmablasts and transitional B cells; however, B-cell immune perturbations were unrelated to HIV-1 reservoir size and normalized after initiation of antiretroviral therapy. Clinical Trials Registration. NCT02369406.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Kenneth Maswabi, Gbolahan Ajibola
Förderung
- FIC NIH HHS
- NIAID NIH HHS
- CCR NIH HHS
- NCI NIH HHS
- National Institutes of Health
- Frederick National Laboratory for Cancer Research
- Frederick National Laboratory, Center for Cancer Research
- Bill and Melinda Gates Foundation
Zitieren
APA
Hartana, C. A., Broncano, P. G., Maswabi, K., Ajibola, G., Moyo, S., Mohammed, T., Maphorisa, C., Makhema, J., Powis, K. M., Lockman, S., Burbelo, P. D., Gao, C., Yu, X. G., Kuritzkes, D. R., Shapiro, R., & Lichterfeld, M. (2023). Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates. The Journal of Infectious Diseases, 228(3), 281-286. https://doi.org/10.1093/infdis/jiad173
Vancouver
Hartana CA, Broncano PG, Maswabi K, Ajibola G, Moyo S, Mohammed T, et al. Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates. The Journal of Infectious Diseases. 2023;228(3):281-286. doi:10.1093/infdis/jiad173
BibTeX
@article{Hartana2023,
author = {Hartana, Ciputra Adijaya and Broncano, Pilar Garcia and Maswabi, Kenneth and Ajibola, Gbolahan and Moyo, Sikhulile and Mohammed, Terence and Maphorisa, Comfort and Makhema, Joseph and Powis, Kathleen M and Lockman, Shahin and Burbelo, Peter D and Gao, Ce and Yu, Xu G and Kuritzkes, Daniel R and Shapiro, Roger and Lichterfeld, Mathias},
title = {Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {228},
number = {3},
pages = {281--286},
doi = {10.1093/infdis/jiad173}
}
EUVIMED